Scientists discover "undead" jellyfish, scholars reveal aging mechanism, human lifespan or extension?

In the early years, scientists discovered that the lighthouse jellyfish would degenerate itself into a juvenile state under certain conditions, and then grow into a new jellyfish, achieving immortality through the so-called "rewinding time". Like the common jellyfish, the lighthouse jellyfish reproduces sexually and dies after laying eggs, but it is different in that it can "turn back" to its original polyd state when grown.

Since jellyfish can achieve "reverse growth", can humans do the same? The answer, of course, is no, unless you want to become a giant jellyfish with human DNA. But even so, the wealthy, who have an extraordinary obsession with "immortality", spend extravagantly on things like "extending their lives" and even find new ways to do so. They are more willing to believe that human beings can eventually find a way to overcome death.

Silicon Valley billionaires develop "immortal" drugs, spending a lot of money for "eternal life"

Larry Ellison is the boss of Oracle, the world's largest database software company, with products all over the world. Like most billionaires, Oracle Software CEO Larry Ellison wants to live a long life. To this end, Ellison created a medical foundation, the Ellison Medical Foundation, dedicated to the research and development of anti-aging drugs. Not only that, Ellison's foundation has also donated $100 million to eradicate polio. When answering a reporter's question about why he would continue to invest tens of billions of dollars in anti-aging research, he said: "Death makes me angry."

In addition to Ellison, Facebook founder Zuckerberg and his wife continued to invest 3 billion US dollars, striving for scientists to achieve effective intervention and management of all diseases in the 21st century; food tycoon Merck invested more than 500 million US dollars in a building dedicated to longevity and healthy diet Research institutions, want to live to 125 years old. Driven by huge sums of money, life technology has accelerated its iteration, and the dream of the rich to spend a lot of money just to seek "eternal life" seems to be becoming a reality step by step, among which there are some amazing moves in the field of biotechnology.

A new breakthrough in the field of biotechnology, the time factor greatly extends the lifespan of mice

As early as 2013, Sinclair, a professor of genetics at Harvard Medical School, was the first to announce a β-nicotinamide derivative (the core mechanism component of Boos that is popular among high-net-worth groups), which can effectively supplement the body's important coenzyme I, which will change with age. The decrease in the growth content is considered to be an important reason for the acceleration of human aging. In the experiment, by administering this β-nicotinamide derivative, the cell metabolism and related aging indicators of the test object were improved, and even the survival period was extended by one third, which is about an increase of 30 years of human lifespan. Professor Sinclair himself was selected as one of the "100 Most Influential People in the World" by "TIME" for his outstanding contributions in the field of anti-aging.

As the mechanism of action of this β-nicotinamide derivative related to aging and lifespan has been continuously explored, well-known academic journals represented by "Cell" have published articles to elaborate, and the substance has also quickly attracted the interest of many rich people, but At that time, due to the high cost of production and purification that could only be obtained through individual laboratories at that time, only a few people could have access to it. The wealthy people represented by Li Chaoren and the scientific researchers represented by Sinclair himself became the first to eat the "crab". batch of people.

According to reports, Li Chaoren had obtained and tried the precursor of Boos β-nicotinamide through personal channels in 2017, claiming that he felt 20 years younger and spent 200 million shares in related technology companies. Sinclair's own father, who is 80 years old, insists on taking it for a period of time and still engages in mountaineering and surfing, which he loved when he was young. The physical condition shown is completely different from that of his peers.

The exposure of many academic documents and media reports has made this β-nicotinamide derivative and its anti-aging mechanism gradually known to the public. It is reported that Boos has successfully achieved mass production and popularization of the substance through the green enzyme directional technology, so that it can finally flow into the hands of most high-net-worth individuals other than a few rich people, but the cost of taking it is still not cheap. According to the consumption big data represented by JD.com, keywords such as this substance and Boos have become the hot search terms on the platform, and the cumulative harvest of intention groups reaches hundreds of thousands.

Aging intervention leverages the 100 billion market, further widening the gap between rich and poor life expectancy

The huge breakthrough brought by the field of life science and technology has given β-nicotinamide substances the potential of a billion-dollar market. Merrill Lynch, a well-known investment bank, believes that it is expected to achieve a huge scale of 600 billion US dollars in 2015, and Sinclair, the main scientist of the substance, is also planning to raise another 100 million US dollars after the realization of 50 million US dollars in Series B financing to further expand the substance and the relationship. For research related to aging and lifespan intervention, it is reported that the previous $50 million financing has brought about a $500 million valuation to his biotechnology company.

Going back to the biotech achievement itself, the expectations brought about by its aging and longevity intervention mechanism are right in the "presence" of the rich. Real estate tycoon Lee Shau Kee once said without hesitation, "I am willing to exchange 100 billion for 30 years of youth". The cycle of wealth and life expectancy, with the help of more and more cutting-edge science and technology, gradually shows that the rich have a longer life expectancy than ordinary people. . A Stanford University study found that the average life expectancy of the top 1% of the rich in the United States reached 87.3 years, which is 15 years longer than the average life expectancy of the top 1%.

According to Darwin's theory of evolution, we are in an era of rapid technological development. With the blessing of wealth and life-extending black technology, a group of rich people will take the lead in breaking through the ceiling of life expectancy. Wealth is becoming an important factor affecting life expectancy. The gap in human lifespan may be further widened, and what should be done for those who do not have the opportunity to enjoy the achievements of science and technology, this is a question worth pondering.